Predominance of CTX-M-9 Group Among ESBL-Producing Isolated from Healthy Individuals in Japan.

Takashi Masui, Ryuichi Nakano, Akiyo Nakano, Kai Saito, Yuki Suzuki, Naoki Kakuta, Saori Horiuchi, Kousuke Tsubaki, Tadashi Kitahara, Hisakazu Yano
Author Information
  1. Takashi Masui: Department of Otolaryngology-Head and Neck Surgery, Nara Medical University, Kashihara, Japan.
  2. Ryuichi Nakano: Department of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Japan. ORCID
  3. Akiyo Nakano: Department of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Japan.
  4. Kai Saito: Department of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Japan.
  5. Yuki Suzuki: Department of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Japan.
  6. Naoki Kakuta: Department of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Japan.
  7. Saori Horiuchi: Department of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Japan.
  8. Kousuke Tsubaki: Department of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Japan.
  9. Tadashi Kitahara: Department of Otolaryngology-Head and Neck Surgery, Nara Medical University, Kashihara, Japan.
  10. Hisakazu Yano: Department of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Japan.

Abstract

The detection rate of extended-spectrum β-lactamase (ESBL)-producing Enterobacterales, microorganisms associated with health care settings, has significantly increased worldwide. Moreover, their community incidence has increased in several countries. In this study, we investigated the prevalence and genetic diversity of ESBL-producing isolated from 547 nonduplicated stool specimens from healthy Japanese individuals, between 2015 and 2019. were isolated on deoxycholate-hydrogen sulfide-lactose (DHL) agar and identified by MALDI-TOF MS, ESBL were screened through disk diffusion method (cefotaxime with or without clavulanate), and genetic detection and genotyping were performed by PCR and DNA sequencing. Clonal similarities between ESBL-producing and nonproducing isolates were assessed by multilocus sequence typing (MLST). The prevalence of ESBL-producing was 9.7% (53/547). These bacteria harbored CTX-M genes, from which CTX-M-9 (31/53, 58.5%) and CTX-M-1 (13/53, 24.5%) groups were the predominant. The MLST analysis revealed that ST131 genotype prevailed within ESBL-producing (15/53), whereas ST95 (10/53) and ST73 (8/53) prevailed among non-ESBL producers, with ST131 being present in only four isolates. Overall, a high prevalence rate of CTX-M-type ESBL-producing was detected. CTX-M-9 group-producing ST131 predominated among healthy Japanese individuals, similar to that observed in hospital isolates. CTX-M-type ESBL may disseminate clonally among hospital patients and subsequently, within the community.

Keywords

MeSH Term

Adult
Anti-Bacterial Agents
Carrier State
Drug Resistance, Multiple, Bacterial
Escherichia coli
Escherichia coli Proteins
Female
Genes, Bacterial
Genotype
Humans
Japan
Male
Microbial Sensitivity Tests
Multilocus Sequence Typing
Young Adult
beta-Lactamases

Chemicals

Anti-Bacterial Agents
Escherichia coli Proteins
beta-lactamase TEM-3
beta-Lactamases
beta-lactamase CTX-M, E coli

Word Cloud

Similar Articles

Cited By